The Day’s Play Edition 95: New copper discoveries, funded production pathways and rare earth milestones | WCN, TCG, REZ

White Cliff Minerals (ASX:WCN)

New High-Grade Copper Zone Confirmed At Danvers

The Play

• New high-grade copper discovery confirmed beyond the main Teshierpi Fault Zone.

• Drillhole DAN26015 returned 79.24m at 1.59% Cu including 24.38m at 3.05% Cu.
• Copper sulphides now span more than 6km of interpreted strike.
• Copper mineralised footprint now exceeds 3.1km of strike length.
• Copper mineralisation confirmed on both contacts of the regional fault zone.

The Pitch

• Rae Copper Project is located in Nunavut, Canada.

• Danvers drilling targets the regional Teshierpi Fault Zone.
• Teshierpi Fault Zone extends more than 10km across the property.
• Drilling targets electromagnetic anomalies along the Teshierpi Fault Zone.
• 2026 drilling uses wide-spaced holes across the project area.

The Next Overs

• Diamond drilling to commence at Danvers following 2026 discoveries.

• Oriented core drilling planned to determine mineralisation orientation.
• Further infill and step-out drilling planned around 2026 discoveries.

Read full ASX Announcement here.

Turaco Gold (ASX:TCG)

Afema PFS Supports +200,000ozpa Gold Operation

The Play

• Maiden Probable Ore Reserve declared at 55.1Mt at 1.1g/t for 1.91Moz gold.

• PFS outlines average production of approximately 200,000oz annually over 10.3 years.
• Life-of-mine recovered gold production totals 2.0Moz at 87-88% recovery.
• Study estimates total development capital of US$410 million including contingency.
• Post-tax NPV(5%) reaches US$1.49 billion at a US$3,000/oz gold price.

The Pitch

• Afema hosts a 116.7Mt Mineral Resource at 1.2g/t for 4.65Moz gold.

• The project is located in southeast Côte d’Ivoire within a granted mining permit.
• Mining is based on conventional open-pit operations with no underground mining considered.
• Processing combines a 4Mtpa CIL circuit and 2Mtpa flotation/UFG/CIL circuit.
• Ore reserves currently cover Woulo Woulo, Jonction, Anuiri and Asupiri deposits.

The Next Overs

• Turaco will advance the study to definitive feasibility level.

• Environmental and social impact assessment work will continue through CY26.
• Detailed design and engineering work will commence to support project development.

Read full ASX Announcement here.

Resources & Energy Group (ASX:REZ)

Maranoa Mining Deal Secures Funded Production Pathway

The Play

• REZ executed a binding term sheet for mining and production at Maranoa.

• Rembrandt will fund 100% of drilling, mining and processing capital requirements.
• REZ retains 100% tenement ownership and legal operator designation.
• Profit sharing ranges from 50/50 at A$3,000/oz to 60/40 in REZ’s favour at A$7,000/oz.
• Primary processing is planned through third-party toll milling arrangements.

The Pitch

• Maranoa is located within REZ’s East Menzies Gold Project in Western Australia.

• Rembrandt will operate as contract operator under a Tribute Mining Agreement.
• REZ retains zero capital commitment unless a 300+koz Au inventory is defined.
• Operating expenses will be recovered on an open-book cost-plus-zero basis.
• REZ will receive a A$200,000 annual management fee plus GST.

The Next Overs

• Formal mining agreement documentation is targeted within 30 days.

• Rembrandt will arrange and fund development, mining and processing activities.
• Processing evaluations will continue across toll milling and vat leach routes.

Read full ASX Announcement here.

Victory Metals (ASX:VTM)

Pilot Plant Delivers 59x Rare Earth Upgrade

The Play

• Continuous pilot-scale flotation produced a 7.1% TREO concentrate from 1,195ppm feed.

• Results were generated from a continuously fed circuit operating at 12x previous test scale.
• The concentrate delivered a 59x upgrade while maintaining a 40% HREO ratio.
• The concentrate contained 2,777ppm Dy₂O₃, 479ppm Tb₄O₇ and 1.77wt% Y₂O₃.
• Thorium and uranium activity levels indicate concentrate can be shipped as general cargo.

The Pitch

• North Stanmore is a heavy rare earth project located in Western Australia.

• The flotation feed comprised 65 samples from 25 drill holes across the deposit.
• The pilot plant is owned and operated by Victory at its Perth facility.
• The flotation circuit uses conventional low-cost flotation processing.
• Heavy rare earth oxides account for approximately 40% of the concentrate basket.

The Next Overs

• Victory will produce larger volumes of concentrate for potential offtake partners.

• Results will feed directly into the upcoming Pre-Feasibility Study.
• Concentrate samples will support evaluation, qualification and sampling programs.

Read full ASX Announcement here.

Critica (ASX:CRI)

Commercial-Grade Rare Earth Products Advance Jupiter Study

The Play

• Commercial-grade MREC and MREO products were successfully produced from Jupiter.

• MREC containing approximately 58% TREO and MREO containing approximately 97% TREO were produced.
• Jupiter beneficiation achieved up to a 14x upgrade factor and approximately 81% Magnet REO recovery.
• Resource optimisation was completed following 145 Jupiter infill drill holes.
• Jupiter and Mt Lindsay Scoping Studies remain on track for Q3 2026 completion.

The Pitch

• Jupiter is a rare earth, gallium and yttrium project in Western Australia.

• Mt Lindsay is a tin-tungsten project located in Tasmania.
• Jupiter beneficiation achieved approximately 71% TREO recovery and 90%-95% mass rejection.
• Approximately 63% gallium extraction was achieved using the Jupiter hydrometallurgical flowsheet.
• Critica secured $300,000 in non-dilutive funding for Jupiter metallurgical development.

The Next Overs

• SRK Consulting will complete an updated Jupiter Mineral Resource Estimate.

• Product qualification and downstream engagement activities will continue at Jupiter.
• Jupiter and Mt Lindsay Scoping Studies are targeted for completion during Q3 2026.

Read full ASX Announcement here.

AIC Mines (ASX:A1M)

High-Grade Continuity Confirmed At Jericho’s Jolly Shoot

The Play

• High-grade copper, gold and silver continuity confirmed at the Jolly shoot.

• Underground drilling returned higher copper, gold and silver grades than expected.
• Surface drilling extended mineralisation into the previously undrilled upper zone.
• JEDD109 returned 2.2m at 7.1% Cu, 1.0g/t Au and 5.9g/t Ag.
• JY023 returned 3.4m at 4.4% Cu, 1.5g/t Au and 2.8g/t Ag.

The Pitch

• Jericho is located near the Eloise copper mine in North Queensland.

• Mineralisation at Jericho extends across a 5km strike length.
• Jericho remains open to the north and south.
• Jolly is a higher-grade shoot within the J1 lens.
• Mineralisation occurs predominantly within parallel J1 and J2 lenses.

The Next Overs

• Drilling into the Inferred Resource portion of Jolly North is ongoing.

• Underground drilling remains focused on the Jolly shoot south of the JAD.
• Additional drilling continues within the Jolly North resource area.

Read full ASX Announcement here.

Hillgrove Resources (ASX:HGO)

High-Grade Emily Star Results Support Stage 2 FID

The Play

• High-grade copper-gold continuity confirmed through underground drilling at Emily Star.

• Assay results broadly align with the 2024 Emily Star Mineral Resource Estimate.
• 26KVUG0933 returned 19m at 1.49% Cu and 0.13g/t Au.
• 26KVUG0932 returned 15.87m at 1.53% Cu and 0.21g/t Au.
• Drilling results support the Stage 2 investment decision process.

The Pitch

• Emily Star is located within the Kanmantoo Copper Mine in South Australia.

• Drilling is being conducted from the Emily Star Exploration Incline.
• The incline enables shorter and more optimally orientated drill holes.
• The current program targets Emily Star mineralisation and northern extensions.
• Emily Star drilling forms part of ongoing underground diamond drilling activities.

The Next Overs

• Drilling at Emily Star will continue into the September Quarter.

• Studies continue across geotechnical conditions, ventilation and mine planning.
• All results will feed into the 2026 Mineral Resource Estimate update.

Read full ASX Announcement here.

Benz Mining Corp (ASX:BNZ)

High Gold Recoveries Confirmed Across Icon Mineralisation

The Play

• Higher-grade Icon core returned average gold extraction of ~95.5% within 24 hours.
• Strong gold recoveries were maintained across all tested mineralisation grade ranges.
• Mineralised halo material averaging ~0.2 g/t Au achieved ~89% extraction.
• Gold extraction was generally completed within 8 to 24 hours.
• Average cyanide consumption ranged from 0.18 to 0.22 kg/t NaCN.

The Pitch

• Icon is part of the Glenburgh Gold Project in Western Australia.

• Testwork assessed higher-grade core, mid-grade mineralisation and mineralised halo material.
• Test samples were ground to a nominal P80 of 75 µm.
• Glenburgh hosts Hurricane, Icon and Thunderbolt mineralised camps.
• Glenburgh drilling is ramping toward 12 operational RC drill shifts.

The Next Overs

• Repeat and confirmatory cyanidation testwork planned on selected samples.

• Additional testwork planned across the mineralised halo and higher-grade core.
• Gravity recovery and leach response testing will continue by material type.

Read full ASX Announcement here.

RocketDNA (ASX:RKT)

RocketDNA Moves To Full Ownership Of WA Subsidiary

The Play

• RocketDNA agreed to acquire the remaining 40% of RocketDNA (WA).

• The transaction increases ownership from 60% to 100%.
• The acquisition removes the subsidiary’s reported 40% non-controlling interest.
• Consideration totals A$1M and will be satisfied entirely in shares.
• RocketDNA will issue 41,767,605 shares representing approximately 3.5% of issued capital.

The Pitch

• RocketDNA (WA) is the group’s established Western Australian operating subsidiary.

• Most of the group’s Australian revenue is recognised through RocketDNA (WA).
• RocketDNA has controlled and consolidated the subsidiary since September 2021.
• The transaction does not change operations, customers, strategy or net assets.
• The transaction does not change reported consolidated revenue or profit after tax.

The Next Overs

• Completion remains subject to customary conditions within 90 days.

• Intercompany loan arrangements will be amended onto commercial terms.
• RocketDNA will issue consideration shares on transaction completion.

Read full ASX Announcement here.

1414 Degrees (ASX:14D)

SiNTL Selected For Satellite And Spacecraft Testing Program

The Play

• SiNTL gains a space-sector pathway through Orbit Boy partnership.
• Orbit Boy will test SiNTL batteries for satellite, rocket and spacecraft applications.
• Orbit Boy will assist live in-space testing of SiNTL-based batteries aboard satellites.
• Testing may extend to Orbit Boy’s Solaris space-based defence laser.
• 14D will subscribe A$500,000 in Orbit Express under the agreement.

The Pitch

• SiNTL is a silicon-anode battery technology developed under exclusive global licence.

• Orbit Boy operates from Turin, Italy as a space launch company.
• Orbit Boy has developed launcher, satellite servicing and defence laser systems.
• Orbit Boy advises its launch technology has been tested across approximately 500 launches.
• Orbit Boy partners with ESA, KASA, POLSA and other space agencies.

The Next Overs

• European satellite laboratories will assess SiNTL battery deployment readiness.

• Orbit Boy will seek satellite-based live testing and evaluation opportunities.
• Six-stage validation program includes qualification testing and final assessment.

Read full ASX Announcement here.

Island Pharmaceuticals (ASX:ILA)

FDA Grants Orphan Drug Designation For Galidesivir

The Play

• The FDA granted Orphan Drug Designation to Galidesivir for Marburg post-exposure prophylaxis.

• The designation represents a regulatory milestone for the Galidesivir program.
• Orphan Drug Designation provides eligibility for 7 years of US market exclusivity upon approval.
• The designation provides exemption from certain FDA application fees and regulatory assistance.
• The milestone strengthens the program ahead of dose optimisation initiatives next quarter.

The Pitch

• Galidesivir is being advanced under the FDA Animal Rule pathway.

• The program targets post-exposure prophylaxis of Marburg virus disease.
• Island expanded its CRADA with the US Army Medical Research Institute of Infectious Diseases.
• The company has secured non-human primate supply for the planned dose optimisation study.
• Galidesivir is a clinical-stage antiviral with activity across more than 20 RNA viruses.

The Next Overs

• Dose optimisation initiatives are scheduled to commence next quarter.

• GMP manufacturing activities will continue in support of development.
• Preparations for pivotal studies under the FDA Animal Rule pathway will continue.

Read full ASX Announcement here.